AUTOIMMUNITY REVIEWS

Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications.

Micrornas in rheumatoid arthritis: From pathogenesis to clinical impact.

Innate immune-responses and their role in driving autoimmunity.

An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment.

Systemic rheumatic diseases: From biological agents to small molecules.

Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review.

Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review.

Next-generation Fc receptor-targeting biologics for autoimmune diseases.

Rheumatoid arthritis (RA) and cardiovascular disease.

Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease.

Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.

Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis.

Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.

Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies.

A review of the evidence for a natalizumab exit strategy for patients with multiple sclerosis.

Lethal immunoglobulins: Autoantibodies and sudden cardiac death.

G-CSF-induced aortitis: Two cases and review of the literature.

Extracellular vesicles in autoimmune vasculitis - Little dirts light the fire in blood vessels.

Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus.

Complex regional pain syndrome - False hopes and miscommunications.

Amino acid metabolism as drug target in autoimmune diseases.

Impact of tobacco smoking upon disease risk, activity and therapeutic response in systemic lupus erythematosus: A systematic review and meta-analysis.

Refractory lupus nephritis: When, why and how to treat.

Uveitis: Autoimmunity… and beyond.

Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis.

Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review.

Target Therapy in SLE.

Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy.

Liver-associated immune abnormalities.

Cannabinoids in the treatment of rheumatic diseases: Pros and cons.

Adrenal insufficiency in systematic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): A systematic review.

The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases.

Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature.

The Giants (biologicals) against the Pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritis.

STAT signaling as a marker of SLE disease severity and implications for clinical therapy.

Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities.

Can we use NOACS in APS?

Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.

Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis.

Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.

Microvascular heart involvement in systemic autoimmune diseases: The purinergic pathway and therapeutic insights from the biology of the diseases.

Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis.

Large-vessel vasculitis diagnosed between 50 and 60\u202fyears: Case-control study based on 183 cases and 183 controls aged over 60\u202fyears.

Tracheobronchial involvement of relapsing polychondritis.

Biosimilars vs originators: Are they the same?

Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems.

Systemic sclerosis induced by CNS stimulants for ADHD: A case series and review of the literature.